All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Hormonal

Erectile Dysfunction

By FormBlends Medical Team · Last reviewed April 2026

Erectile dysfunction is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects over 30 million men in the United States and becomes more common with age. While PDE5 inhibitors address the vascular component, peptide therapies targeting central arousal pathways and hormonal optimization offer complementary approaches.

Affects over 30 million men in the United States

FormBlends Condition Context

Reviewed May 14, 2026

Use Erectile Dysfunction condition guide as a decision-support page, not a shortcut. Its job is to connect symptoms and treatment options to a safer provider conversation, especially where the search overlaps with condition-specific care. A useful reader should leave with better questions about clinician oversight, evidence quality, safety limits, cost, pharmacy path, and what changes for their own health history.

  • Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
  • Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
  • Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.

Common Symptoms

  • Difficulty achieving erections during sexual activity
  • Inability to maintain erections long enough for intercourse
  • Reduced firmness of erections
  • Reduced morning erections
  • Decreased sexual confidence and performance anxiety
  • Reduced libido accompanying erectile changes

Common Causes

  • Vascular disease reducing penile blood flow
  • Low testosterone affecting nitric oxide and libido
  • Diabetes damaging small blood vessels and nerves
  • Psychological factors including stress and anxiety
  • Medications including SSRIs, beta-blockers, and antihistamines

Treatment Options

Peptide

PT-141 (Bremelanotide)

PT-141 activates melanocortin-4 receptors in the hypothalamus to produce sexual arousal through a central mechanism, making it effective even when vascular medications have limited benefit.

Learn more about PT-141 (Bremelanotide)
TRT

Testosterone Replacement Therapy

In men with confirmed low testosterone, TRT restores the hormonal foundation needed for healthy erectile function, libido, and nitric oxide production.

Learn more about Testosterone Replacement Therapy
Lifestyle

PDE5 Inhibitors

Medications like sildenafil and tadalafil enhance nitric oxide signaling to improve blood flow to the penis. They remain the first-line pharmacological treatment for ED.

Find Treatment for Erectile Dysfunction

Browse clinics near you that treat erectile dysfunction.

Find Clinics

Frequently Asked Questions

What is erectile dysfunction?
Erectile dysfunction is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects over 30 million men in the United States and becomes more common with age. While PDE5 inhibitors address the vascular component, peptide therapies targeting central arousal pathways and hormonal optimization offer complementary approaches.
What are the symptoms of erectile dysfunction?
Difficulty achieving erections during sexual activity, Inability to maintain erections long enough for intercourse, Reduced firmness of erections, Reduced morning erections, Decreased sexual confidence and performance anxiety, Reduced libido accompanying erectile changes.
What treatments are available for erectile dysfunction?
PT-141 (Bremelanotide), Testosterone Replacement Therapy, PDE5 Inhibitors.